Post Date: September 3, 2020
Cincinnati Children’s is participating in ongoing clinical trials of an mRNA-based vaccine under development by Pfizer and BioNTech.
Robert Frenck, MD, Director, Vaccine Research Center, is leading the local effort and is one of the key co-authors of this study that reports early-stage clinical trial results for the first of two versions of the vaccine, The manufacturer has decided to move forward with the second version.
See below for other widely shared research findings from experts at Cincinnati Children’s.
Cincinnati Children’s co-author: Michael Helmrath, MD
Cincinnati Children’s co-authors: (first author) Mariana Stevens, PhD, Kathryn Wikenheiser-Brokamp, MD, PhD, Matthew Weirauch, PhD, Lisa Martin, PhD, Jocelyn Biagini Myers, PhD, and Gurjit Khurana Hershey, MD, PhD
Cincinnati Children’s co-author: Jeffery Epstein, PhD
Cincinnati Children’s co-author: Joel Sorger, MD
Cincinnati Children’s co-author: Lara Danziger-Isakov, MD, MPH
The Research Horizons blog features news and insights about the latest discoveries and innovations developed by the scientists of Cincinnati Children's. This blog does not provide medical advice, diagnosis, or treatment.